Novavax Inc (NVAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 36,250 | 30,659 | 20,915 | 22,076 | 14,688 |
| Cost of Goods | N/A | N/A | N/A | 14,692 | 7,003 |
| Gross Profit | 36,250 | 30,659 | 20,915 | 7,384 | 7,685 |
| Operating Expenses | 193,486 | 114,350 | 73,349 | 37,741 | 29,267 |
| Operating Income | -157,236 | -83,691 | -52,434 | -29,665 | -21,579 |
| Interest Expense | 241 | 157 | 160 | 32 | 9 |
| Other Income | 540 | 901 | 636 | 1,190 | 2,636 |
| Pre-tax Income | -156,937 | -82,947 | -51,958 | -28,507 | -18,952 |
| Income Tax | N/A | N/A | 25 | 0 | 412 |
| Net Income Continuous | -156,937 | -82,947 | -51,983 | -28,507 | -19,364 |
| Net Income | $-156,937 | $-82,947 | $-51,983 | $-28,507 | $-19,364 |
| EPS Basic Total Ops | -12.00 | -7.40 | -6.20 | -4.40 | -3.40 |
| EPS Basic Continuous Ops | -11.97 | -7.35 | -6.13 | -4.33 | -3.41 |
| EPS Diluted Total Ops | -12.00 | -7.40 | -6.20 | -4.40 | -3.40 |
| EPS Diluted Continuous Ops | -11.97 | -7.35 | -6.13 | -4.33 | -3.41 |
| EBITDA(a) | $-151,253 | $-78,852 | $-49,336 | $-28,017 | $-19,649 |